NYSE:ADPT
Delisted
Adeptus Health Inc Stock News
$29.54
+1.56 (+5.58%)
At Close: Apr 20, 2020
Adaptive Biotechnologies Corporation (ADPT) Q2 2022 Earnings Call Transcript
04:00am, Thursday, 04'th Aug 2022 The Motley Fool
ADPT earnings call for the period ending June 30, 2022.
Adaptive Biotechnologies (ADPT) Reports Q2 Loss, Tops Revenue Estimates
09:35pm, Wednesday, 03'rd Aug 2022 Zacks Investment Research
Adaptive Biotechnologies (ADPT) delivered earnings and revenue surprises of 7.50% and 0.82%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
Adaptive Biotechnologies Corporation (ADPT) CEO Chad Robins on Q2 2022 Results - Earnings Call Transcript
09:29pm, Wednesday, 03'rd Aug 2022
Adaptive Biotechnologies Corporation (NASDAQ:ADPT ) Q2 2022 Results Conference Call August 3, 2022 4:30 PM ET Company Participants Karina Calzadilla - Head, IR Chad Robins - Co-Founder, CEO Tycho Pete
Adaptive Biotechnologies Reports Second Quarter 2022 Financial Results
08:05pm, Wednesday, 03'rd Aug 2022 GlobeNewswire Inc.
SEATTLE, Aug. 03, 2022 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation (“Adaptive Biotechnologies”) (Nasdaq: ADPT), a commercial stage biotechnology company that aims to translate the g
Adaptive Biotechnologies (ADPT) Reports Q2 Loss, Tops Revenue Estimates
06:48pm, Wednesday, 03'rd Aug 2022
Adaptive Biotechnologies (ADPT) delivered earnings and revenue surprises of 7.50% and 0.82%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
Is a Surprise Coming for Adaptive Biotechnologies (ADPT) This Earnings Season?
02:07pm, Tuesday, 02'nd Aug 2022 Zacks Investment Research
Adaptive Biotechnologies (ADPT) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
BD (BDX) Gears Up for Q3 Earnings: What's in the Offing?
12:31pm, Tuesday, 02'nd Aug 2022 Zacks Investment Research
Continued strength in BD's (BDX) Interventional segment is expected to have driven up Q3 sales.
CVS Health (CVS) to Report Q2 Earnings: What's in the Cards?
03:26pm, Monday, 01'st Aug 2022 Zacks Investment Research
Robust retail and pharmacy sales performance are likely to have driven CVS Health's (CVS) Q2 performance.
Earnings Preview: NGM Biopharmaceuticals (NGM) Q2 Earnings Expected to Decline
02:02pm, Thursday, 28'th Jul 2022 Zacks Investment Research
NGM Biopharmaceuticals (NGM) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Adaptive Biotechnologies (ADPT) Expected to Beat Earnings Estimates: Should You Buy?
02:01pm, Wednesday, 27'th Jul 2022 Zacks Investment Research
Adaptive Biotechnologies (ADPT) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Top Health Care Stocks To Buy Right Now? 4 To Watch
02:23pm, Saturday, 09'th Jul 2022
Check these health care stocks out for your watchlist right now
Adaptive Biotechnologies to Report Second Quarter of 2022 Financial Results on August 3, 2022
08:05pm, Friday, 08'th Jul 2022 GlobeNewswire Inc.
SEATTLE, July 08, 2022 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation (Nasdaq: ADPT) a commercial-stage biotechnology company that aims to translate the genetics of the adaptive immune s
Adaptive Biotechnologies to Report Second Quarter of 2022 Financial Results on August 3, 2022
04:05pm, Friday, 08'th Jul 2022
SEATTLE, July 08, 2022 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation (Nasdaq: ADPT) a commercial-stage biotechnology company that aims to translate the genetics of the adaptive immune sys
Why Adaptive Biotechnologies Shares Are Rising
03:07pm, Wednesday, 15'th Jun 2022
Adaptive Biotechnologies Corp (NASDAQ: ADPT) shares are trading higher by 12.58% to $7.25 after the company launched T-Detect Lyme, to help diagnose early lyme disease. Adaptive Biotechnologies says,
Adaptive Biotechnologies Launches T-Detect™ Lyme, A New T-Cell Clinical Test for the Detection of Early Lyme Disease
11:30am, Wednesday, 15'th Jun 2022 GlobeNewswire Inc.
T-Detect Lyme enables patients and healthcare providers to detect early Lyme disease with greater sensitivity than leading antibody tests T-Detect Lyme enables patients and healthcare providers to det
